IDEXX Laboratories Inc. (IDXX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
ONE IDEXX DRIVE WESTBROOK, ME 04092-2041 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 288 | 454 | 113 | 144 | 384 | 90 | |||
| Cash and cash equivalent | 288 | 454 | 113 | 144 | 384 | 90 | |||
| Receivables | 474 | 457 | 401 | 368 | 331 | 269 | |||
| Inventory, net of allowances, customer advances and progress billings | 382 | 380 | 368 | 269 | 210 | 195 | |||
| Inventory | 382 | 380 | 368 | 269 | 210 | 195 | |||
| Other current assets | 256 | 204 | 220 | 174 | 138 | 125 | |||
| Total current assets: | 1,400 | 1,495 | 1,101 | 956 | 1,063 | 680 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 116 | 115 | 119 | 105 | 91 | 81 | |||
| Property, plant and equipment | 713 | 702 | 649 | 588 | 555 | 534 | |||
| Intangible assets, net (including goodwill) | 517 | 450 | 459 | 458 | 296 | 298 | |||
| Goodwill | 405 | 366 | 362 | 359 | 243 | 240 | |||
| Intangible assets, net (excluding goodwill) | 112 | 85 | 98 | 99 | 53 | 58 | |||
| Other noncurrent assets | 548 | 497 | 418 | 330 | 290 | 240 | |||
| Total noncurrent assets: | 1,894 | 1,765 | 1,645 | 1,482 | 1,232 | 1,153 | |||
| TOTAL ASSETS: | 3,293 | 3,260 | 2,747 | 2,437 | 2,295 | 1,832 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 616 | 589 | 544 | 575 | 490 | 395 | |||
| Accounts payable | 114 | 111 | 110 | 116 | 75 | 72 | |||
| Accrued liabilities | 502 | 479 | 434 | 459 | 416 | 323 | |||
| Deferred revenue | 34 | 37 | 38 | 40 | 43 | 41 | |||
| Debt | 168 | 75 | 75 | 75 | 50 | 289 | |||
| Other undisclosed current liabilities | 250 | 250 | 579 | 74 | |||||
| Total current liabilities: | 1,068 | 952 | 1,236 | 764 | 583 | 725 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 450 | 623 | 694 | 863 | 936 | 766 | |||
| Long-term debt, excluding current maturities | 450 | 623 | 694 | 775 | 858 | 699 | |||
| Liabilities, other than long-term debt | 180 | 201 | 208 | 121 | 143 | 163 | |||
| Deferred revenue | 27 | 29 | 31 | 41 | 46 | 49 | |||
| Deferred income tax liabilities | 11 | 7 | 8 | 9 | 12 | 33 | |||
| Other liabilities | 44 | 66 | 68 | 71 | 86 | 81 | |||
| Operating lease, liability | 98 | 100 | 101 | 87 | 77 | 67 | |||
| Total noncurrent liabilities: | 630 | 824 | 902 | 984 | 1,079 | 929 | |||
| Total liabilities: | 1,698 | 1,775 | 2,138 | 1,747 | 1,662 | 1,655 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 1,595 | 1,485 | 609 | 690 | 632 | 177 | |||
| Common stock | 11 | 11 | 11 | 11 | 11 | 11 | |||
| Treasury stock, value | (5,334) | (4,475) | (4,392) | (3,571) | (2,800) | (2,601) | |||
| Additional paid in capital | 1,674 | 1,570 | 1,463 | 1,377 | 1,295 | 1,214 | |||
| Accumulated other comprehensive loss | (94) | (71) | (78) | (53) | (54) | (46) | |||
| Retained earnings | 5,332 | 4,445 | 3,600 | 2,920 | 2,176 | 1,596 | |||
| Other undisclosed equity, attributable to parent | 6 | 6 | 5 | 6 | 5 | 4 | |||
| Equity, attributable to noncontrolling interest | 1 | 0 | |||||||
| Total equity: | 1,595 | 1,485 | 609 | 690 | 633 | 178 | |||
| TOTAL LIABILITIES AND EQUITY: | 3,293 | 3,260 | 2,747 | 2,437 | 2,295 | 1,832 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | ||
| Cost of revenue | (1,519) | (1,471) | (1,363) | (1,326) | (1,136) | (1,041) | ||
| Cost of product and service sold | (1,519) | |||||||
| Gross profit: | 2,379 | 2,190 | 2,004 | 1,889 | 1,571 | 1,366 | ||
| Operating expenses | (1,251) | (1,093) | (1,106) | (957) | (877) | (813) | ||
| Operating income: | 1,128 | 1,097 | 899 | 932 | 695 | 553 | ||
| Interest and debt expense | (31) | (42) | (40) | (30) | (33) | (31) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1 | 0 | ||||||
| Income from continuing operations before equity method investments, income taxes: | 1,097 | 1,056 | 859 | 902 | 662 | 522 | ||
| Other undisclosed income from continuing operations before income taxes | 13 | 6 | 1 | 0 | ||||
| Income from continuing operations before income taxes: | 1,110 | 1,061 | 860 | 903 | 662 | 522 | ||
| Income tax expense | (222) | (216) | (181) | (158) | (80) | (94) | ||
| Income from continuing operations: | 888 | 845 | 679 | 745 | 582 | 428 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 745 | 582 | 428 | |
| Net income: | 888 | 845 | 679 | 745 | 582 | 428 | ||
| Net income (loss) attributable to noncontrolling interest | 0 | (0) | (0) | |||||
| Net income available to common stockholders, diluted: | 888 | 845 | 679 | 745 | 582 | 428 | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 888 | 845 | 679 | 745 | 582 | 428 | ||
| Other comprehensive income (loss) | (22) | 7 | (24) | 0 | (7) | (4) | ||
| Other undisclosed comprehensive loss | ||||||||
| Comprehensive income: | 865 | 852 | 655 | 745 | 575 | 423 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 0 | (0) | (0) | |||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | ||||||||
| Comprehensive income, net of tax, attributable to parent: | 865 | 852 | 655 | 745 | 574 | 423 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.